538 related articles for article (PubMed ID: 34478821)
1. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
2. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
[TBL] [Abstract][Full Text] [Related]
3. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.
Sy BT; Hoan NX; Tong HV; Meyer CG; Toan NL; Song LH; Bock CT; Velavan TP
World J Gastroenterol; 2018 Jan; 24(2):248-256. PubMed ID: 29375210
[TBL] [Abstract][Full Text] [Related]
5. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.
Hoan NX; Huyen PTM; Binh MT; Trung NT; Giang DP; Linh BT; Dung DTN; Pallerla SR; Kremsner PG; Velavan TP; Bang MH; Song LH
Sci Rep; 2021 Apr; 11(1):7772. PubMed ID: 33833369
[TBL] [Abstract][Full Text] [Related]
7. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
9. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus.
Hoan NX; Khuyen N; Giang DP; Binh MT; Toan NL; Anh DT; Trung NT; Bang MH; Meyer CG; Velavan TP; Song LH
BMC Med Genet; 2019 Dec; 20(1):201. PubMed ID: 31864292
[TBL] [Abstract][Full Text] [Related]
11. The association between TNFR gene polymorphisms and the risk of Hepatitis B Virus-Related Liver Diseases in Chinese population.
Ma L; Chen S; Mao X; Lu Y; Zhang X; Lao X; Qin X; Li S
Sci Rep; 2018 Jun; 8(1):9240. PubMed ID: 29915336
[TBL] [Abstract][Full Text] [Related]
12. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
Zhang G; Li N; Zhang P; Li F; Yang C; Zhu Q; Han Q; Lv Y; Zhou Z; Liu Z
Immunol Lett; 2014 Nov; 162(1 Pt A):212-6. PubMed ID: 25218665
[TBL] [Abstract][Full Text] [Related]
13. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
14. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
16. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
[TBL] [Abstract][Full Text] [Related]
17. Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.
Li N; Zhou Z; Li F; Sang J; Han Q; Lv Y; Zhao W; Li C; Liu Z
Oncotarget; 2017 Jul; 8(28):46020-46033. PubMed ID: 28545019
[TBL] [Abstract][Full Text] [Related]
18. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
Song XM; Li QL; Guo F; Peng H; Guo JJ
Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
[TBL] [Abstract][Full Text] [Related]
19. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.
Cheng HY; Kang PJ; Chuang YH; Wang YH; Jan MC; Wu CF; Lin CL; Liu CJ; Liaw YF; Lin SM; Chen PJ; Lee SD; Yu MW
PLoS One; 2014; 9(11):e95870. PubMed ID: 25427199
[TBL] [Abstract][Full Text] [Related]
20. [Association of circulating levels of soluble PD-1, PD-1 gene polymorphisms with HBV infection and HBV infection-associated hepatocellular carcinoma].
Ma Y; Hao YQ; Bi LQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):863-867. PubMed ID: 37357205
[No Abstract] [Full Text] [Related]
[Next] [New Search]
